Noun
emtricitabine (uncountable)
(pharmacology) A synthetic nucleoside reverse-transcriptase inhibitor C8H10FN3O3S (trademarks Atripla, Complera, Emtriva, Stribild, Truvada) administered orally typically in conjunction with other antiretroviral agents for the treatment of HIV infection.
Because the risks of low-level exposure to efavirenz, emtricitabine, and tenofovir to infants are unknown, and because of the potential for HIV-1 transmission, mothers should be instructed not to breastfeed if they are receiving ATRIPLA. Source: Internet
From Weeks 96 to 144 of the trial, subjects received TRUVADA with efavirenz in place of emtricitabine + tenofovir DF with efavirenz. Source: Internet
Breastfeeding infants whose mothers are being treated with emtricitabine may be at risk for developing viral resistance to emtricitabine. Source: Internet
For additional information about these trials, consult the prescribing information for tenofovir DF and emtricitabine. Source: Internet